Natrelle 133 Plus MICROCELL Tissue Expander— 510(k) K180826

Name: FDA 510(k) clearance K180826
Creator: U.S. Food and Drug Administration
Published: 2018-12-21

Substantially Equivalent

Allergan

FDA 510(k) clearance K180826 for Natrelle 133 Plus MICROCELL Tissue Expander, Substantially Equivalent on 2018-12-21. Applicant: Allergan. Device class: Unclassified.

Clearance details

Applicant: Allergan
Product code: Code LCJ
Device class: Unclassified
Advisory panel: Unknown
Date received: 2018-03-30
Decision date: 2018-12-21
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Irvine, CA, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code LCJ

view all

K254126 — Natrelle 133S Tissue Expanders2026-01-16
K242963 — MENTOR PliaForm Breast Tissue Expander w/ Suture Tabs2025-04-24
K243836 — Mentor CPX 4 PLUS Enhance Breast Tissue Expander2025-01-12
K241918 — MENTOR CPX4 PLUS Enhance Breast Tissue Expander2024-08-02
K211676 — Motiva Flora SmoothSilk Tissue Expander2023-10-13

More clearances from Allergan

view all

K203229 — NATRELLE INSPIRA Single Use Sizers for Gel Implants2021-06-02
K193589 — TrueTear Intranasal Tear Neurostimulator2020-08-31
K182054 — Natrelle 133S Tissue Expander2018-08-29
DEN170086 — TrueTear Intranasal Tear Neurostimulator2018-05-17
K123128 — SERI SURGICAL SCAFFOLD2013-04-25

Adverse events under product code LCJ

product code LCJ

Injury: 2,704
Other: 2
Total: 2,706

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.